AnxietyJADESTRESSNCT07845396
Assessment of Stress and Associated Factors Among Young Adults During the COVID-19 Pandemic
An observational study of Anxiety and Stress, run by GCS Ramsay Santé pour l'Enseignement et la Recherche at 1 site in France.
Trial summary
Since the onset of COVID-19, studies conducted on the general population have shown an increase in the use of antidepressants and anxiolytics, a rise in domestic violence, and heightened demand for peri-urban housing offering more space and a better living environment. Read more about this study
- Who is it for?
- Ages 18 to 29 yearsHealthy volunteers can take part
- Conditions the study is for
- Anxiety, Stress, COVID - 19
- What is being tested?
- Questionnaire
- How many people
- 1,322 participants
- Where
- 1 siteFrance
- Study dates
- 16 May 2022to 27 Jan 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 29 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: Adult patient between 18 and 29 years old
Who may be able to join
- Subject between 18 and 29 years of age.
- Subject capable of understanding the information necessary for the study and participating in online surveys.
- Has read the information sheet describing the research and agreed to participate.
- Subject affiliated with or a beneficiary of a social security scheme.
Who cannot join
- Minor subject
- Subject aged 30 or older
- Difficulty understanding and/or expressing themselves in French
- Subject under legal protection measures (curatorship, guardianship, etc.) or deprived of liberty by judicial or administrative decision
- Pregnant, breastfeeding, or recently delivered woman
Trial locations and contacts
1 site in 1 country.
About this study
Since the onset of COVID-19, studies conducted on the general population have shown an increase in the use of antidepressants and anxiolytics, a rise in domestic violence, and heightened demand for peri-urban housing offering more space and a better living environment.
Queues of students at food distribution points, along with the precarious situations and isolation faced by students with no alternative to cramped living quarters, have exposed the vulnerability of this population to the general public.
Read more
There is a lack of data regarding young people-and students in particular-a group known to be at higher risk than others of exhibiting symptoms of stress, anxiety, or depression.
Depression among students and young adults can impact their social lives, relationships, and quality of life. Indeed, studies have demonstrated a strong correlation between major depressive disorder and poor academic performance, unstable interpersonal relationships, suicidal thoughts and attempts, and difficulties with work.
Existing literature indicates a link between stress and the onset or persistence of anxiety and depression. As these conditions are too often conflated, it is important to distinguish stress from anxiety and depression.
Consequently, a study designed to assess levels of stress, anxiety, and depression-as well as the processes involved in their development and persistence among young people-would facilitate the implementation of appropriate and effective care.
Such a study is all the more necessary in the current context of the COVID-19 pandemic.
Identifying these disorders within specific populations and subgroups would enable the implementation of tailored care strategies, thereby helping to safeguard mental health.
The aim of this study is to assess current levels of stress, anxiety, and depression among young adults and students, and to investigate the underlying determinants.
- Conditions
- Anxiety, Stress, COVID - 19
- Being tested
- Questionnaire
- Medical subject headings
- Anxiety Disorders, COVID-19
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
QuestionnaireOther
- Generalised anxiety disorder questionnaire
- Questionnaire Patient Health Questionnaire-9 (PHQ-9)
- Perceived Stress Scale questionnaire
- Difficulties in Emotion Regulation Scale (DERS-16) questionnaire
- Acceptance and action questionnaire
- Perseverative Thinking Questionnaire
- D-stress questionnaire
- Electrostatic discharge questionnaire
| Study group | Role | What they receive |
|---|---|---|
| patient between 18 and 29 years old | Not described Receives: Other: Questionnaire |
What is being measured
The primary outcome is the main question the study is designed to answer.
Perceived Stress Scale (PSS) score :
The PSS-10 takes about 3 minutes to complete and produces a 0-40 score :
- 0-13 low
- 14-26 moderate
- 27-40 high
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Sep 2026
- Study start16 May 2022
- Primary completion26 Sep 2022
- Study completion27 Jan 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AnxietyStudies of the same condition, open and under way.
- More trials run by GCS Ramsay Santé pour l'Enseignement et la RechercheThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 1,322 participants (actual)
Sponsor and investigators
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07845396
- Sponsor's protocol ID
- 2022-A00100-43
- Acronym
- JADESTRESS
- Status last verified
- Sep 2026
- First submitted
- 18 Sep 2026
- Last updated
- 28 Sep 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessment of Stress and Associated Factors Among Young Adults During the COVID-19 Pandemic
- ClinicalTrials.gov ID
- NCT07845396
- Acronym / sponsor ID
- JADESTRESS / 2022-A00100-43
- Conditions
- Anxiety, Stress, COVID - 19
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,322 participants (actual)
- Lead sponsor
- GCS Ramsay Santé pour l'Enseignement et la RechercheUniversity, hospital or other
- Study start
- 16 May 2022 (actual)
- Primary completion
- 26 Sep 2022 (actual)
- Study completion
- 27 Jan 2023 (actual)
- First posted
- 28 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Since the onset of COVID-19, studies conducted on the general population have shown an increase in the use of antidepressants and anxiolytics, a rise in domestic violence, and heightened demand for peri-urban housing offering more space and a better living environment.
Queues of students at food distribution points, along with the precarious situations and isolation faced by students with no alternative to cramped living quarters, have exposed the vulnerability of this population to the general public.
There is a lack of data regarding young people-and students in particular-a group known to be at higher risk than others of exhibiting symptoms of stress, anxiety, or depression.
Depression among students and young adults can impact their social lives, relationships, and quality of life. Indeed, studies have demonstrated a strong correlation between major depressive disorder and poor academic performance, unstable interpersonal relationships, suicidal thoughts and attempts, and difficulties with work.
Existing literature indicates a link between stress and the onset or persistence of anxiety and depression. As these conditions are too often conflated, it is important to distinguish stress from anxiety and depression.
Consequently, a study designed to assess levels of stress, anxiety, and depression-as well as the processes involved in their development and persistence among young people-would facilitate the implementation of appropriate and effective care.
Such a study is all the more necessary in the current context of the COVID-19 pandemic.
Identifying these disorders within specific populations and subgroups would enable the implementation of tailored care strategies, thereby helping to safeguard mental health.
The aim of this study is to assess current levels of stress, anxiety, and depression among young adults and students, and to investigate the underlying determinants.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| patient between 18 and 29 years old | – | Other: Questionnaire |
Who may qualify
- Ages
- 18 to 29 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Adult patient between 18 and 29 years old
Key inclusion criteria (4 listed)
- Subject between 18 and 29 years of age.
- Subject capable of understanding the information necessary for the study and participating in online surveys.
- Has read the information sheet describing the research and agreed to participate.
- Subject affiliated with or a beneficiary of a social security scheme.
Key exclusion criteria (5 listed)
- Minor subject
- Subject aged 30 or older
- Difficulty understanding and/or expressing themselves in French
- Subject under legal protection measures (curatorship, guardianship, etc.) or deprived of liberty by judicial or administrative decision
- Pregnant, breastfeeding, or recently delivered woman
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Questionnaire* Generalised anxiety disorder questionnaire * Questionnaire Patient Health Questionnaire-9 (PHQ-9) * Perceived Stress Scale questionnaire * Difficulties in Emotion Regulation Scale (DERS-16) questionnaire * Acceptance and action questionnaire * Perseverative Thinking Questionnaire * D-stress questionnaire * Electrostatic discharge questionnaire | Other | patient between 18 and 29 years old |
Primary outcome
Perceived Stress Scale (PSS) score :
Time frame: 3 months
The PSS-10 takes about 3 minutes to complete and produces a 0-40 score : * 0-13 low * 14-26 moderate * 27-40 high
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Sep 2026.
Related trials for Anxiety
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Recruiting
Effect of a Brief Daily Digital Meditation on Well-Being in US Young Adults (BEGIN II)
Mental Health and General Well-being
Not yet recruitingObservational study
Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National Cross-sectional Study
Superior Semicircular Canal Dehiscence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Anxiety and Stress, run by GCS Ramsay Santé pour l'Enseignement et la Recherche at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Perceived Stress Scale (PSS) score : (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2026.